Lars Rönnblom Selected Research

Interferon Type I

1/2021	Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus.
1/2020	C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205.
1/2018	An update on the role of type I interferons in systemic lupus erythematosus and Sjögren's syndrome.
1/2017	Role of interferons in SLE.
10/2016	Cause and consequences of the activated type I interferon system in SLE.
7/2016	The importance of the type I interferon system in autoimmunity.
6/2015	IFN-α production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases.
6/2014	Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant.
3/2013	The interferon signature in autoimmune diseases.
10/2012	B lymphocytes enhance interferon-α production by plasmacytoid dendritic cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Rönnblom Research Topics

Disease

58	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 03/2002
25	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2002
15	Rheumatoid Arthritis 01/2021 - 03/2002
6	Inflammation (Inflammations) 01/2022 - 12/2009
5	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 09/2007
4	Virus Diseases (Viral Diseases) 07/2016 - 12/2003
3	Lupus Nephritis 01/2021 - 01/2013
3	Multiple Sclerosis 10/2020 - 01/2013
3	Dermatomyositis (Dermatopolymyositis) 09/2013 - 09/2007
3	Venous Thrombosis (Deep-Vein Thrombosis) 06/2013 - 04/2004
2	Lymphoma (Lymphomas) 01/2021 - 07/2003
2	COVID-19 01/2021 - 01/2020
2	Nephritis 01/2020 - 01/2011
2	Rheumatic Diseases (Rheumatism) 01/2020 - 01/2018
2	Asthma (Bronchial Asthma) 01/2019 - 04/2015
2	Infections 03/2013 - 01/2013
2	Sjogren's Syndrome (Sjogren Syndrome) 06/2012 - 07/2011
2	Systemic Scleroderma (Systemic Sclerosis) 07/2010 - 05/2009
2	Polymyositis 05/2009 - 09/2007
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022
1	Microscopic Polyangiitis 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Disease Progression 01/2021
1	Ankylosing Spondylitis 01/2021
1	Antisynthetase syndrome 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020
1	Hypersensitivity (Allergy) 01/2019
1	Stroke (Strokes) 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	type 1 Autoimmune polyendocrinopathy syndrome 06/2017
1	Seasonal Allergic Rhinitis (Hay Fever) 04/2015

Drug/Important Bio-Agent (IBA)

22	Interferon Type IIBA 01/2021 - 12/2002
16	AutoantibodiesIBA 01/2022 - 12/2002
13	InterferonsIBA 01/2022 - 02/2010
10	Interferon-alpha (Interferon Alfa)IBA 07/2010 - 12/2002
9	AutoantigensIBA 01/2020 - 03/2002
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2007
7	Antigen-Antibody Complex (Immune Complex)IBA 06/2020 - 06/2006
7	AntibodiesIBA 01/2016 - 09/2003
7	Interferon Regulatory FactorsIBA 01/2013 - 03/2005
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2003
6	RNA (Ribonucleic Acid)IBA 06/2020 - 06/2006
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2013
4	Immunoglobulin G (IgG)IBA 01/2020 - 05/2010
4	CytokinesIBA 10/2018 - 12/2009
4	Nucleic AcidsIBA 10/2018 - 09/2013
3	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 01/2016
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017 - 01/2016
2	Complement System Proteins (Complement)IBA 11/2022 - 01/2011
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 11/2009
2	EpitopesIBA 01/2021 - 01/2013
2	C-Reactive ProteinIBA 01/2020 - 12/2009
2	Cardiolipins (Cardiolipin)IBA 01/2020 - 05/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 12/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 09/2017
2	InterleukinsIBA 01/2020 - 01/2018
2	Peptides (Polypeptides)IBA 01/2020 - 01/2013
2	Antiphospholipid AntibodiesIBA 01/2020 - 06/2013
2	P-2 (P 2)IBA 01/2020 - 01/2018
2	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 01/2016
2	STAT4 Transcription FactorIBA 01/2018 - 01/2013
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2017 - 01/2016
2	HLA-DRB1*04:01 antigenIBA 01/2017 - 01/2016
2	Antiviral Agents (Antivirals)IBA 07/2016 - 12/2003
2	Phospholipids (Phosphatides)FDA LinkGeneric 03/2013 - 05/2010
2	Biological ProductsIBA 03/2013 - 06/2010
2	Immunoglobulin M (IgM)IBA 03/2013 - 01/2013
2	Factor V (Coagulation Factor V)IBA 02/2010 - 04/2007
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2022
1	Complement C4 (Complement Component 4)IBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	Interleukin-33IBA 11/2021
1	AlarminsIBA 11/2021
1	Anti-Citrullinated Protein AntibodiesIBA 01/2021
1	belimumabIBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Immunoglobulin D (IgD)IBA 10/2020
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	CD40 Ligand (CD40L)IBA 01/2020
1	CitrullineIBA 01/2020
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2020
1	ubiquitin isopeptidaseIBA 10/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Interleukin-22 (IL-22)IBA 01/2019
1	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 01/2018
1	Endothelins (Endothelin)IBA 06/2017
1	serum P-component (CIt)IBA 01/2016
1	Collagen Type II (Type II Collagen)IBA 01/2016
1	Surface Antigens (Surface Antigen)IBA 12/2015
1	Immunoglobulin E (IgE)IBA 04/2015

Therapy/Procedure

4	Therapeutics 01/2021 - 12/2002